Revolution Medicines Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Revolution Medicines Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013389
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Revolution Medicines Inc (Revolution Medicines) is a drug discovery company with focus on the development of therapies for cancer. The company’s programs include SHP2 Program and mTOR Program. Its REVBLOCKS platform, an integrated suite of modular synthesis methodologies, facilitates the production of a pipeline of drug candidates with best-in-class properties based on the complex structures found in natural products. The company is also developing REVEAL computational platform, which makes use of the evolutionary process for the selection of chemical scaffolds and guiding the drug design for non-classical drug targets. The company seeks to work in partnership with other organizations for the further development of its programs. Revolution Medicines is headquartered in Redwood City, California, the US.

Revolution Medicines Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Revolution Medicines Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Revolution Medicines Raises Additional USD25 Million in Series A Financing 10
Revolution Medicines Raises USD45 Million in Series A Financing 11
Licensing Agreements 12
Revolution Medicines Enters into Licensing Agreement with University of Illinois 12
Revolution Medicines Inc – Key Competitors 13
Revolution Medicines Inc – Key Employees 14
Revolution Medicines Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Oct 05, 2017: REVOLUTION Medicines Appoints Vincent Miller, M.D. to Board of Directors 16
Mar 20, 2017: REVOLUTION Medicines Appoints Cancer Leader Dr. Stephen Kelsey as President of Research and Development 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Key Facts 2
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Revolution Medicines Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Revolution Medicines Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Revolution Medicines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Revolution Medicines Raises Additional USD25 Million in Series A Financing 10
Revolution Medicines Raises USD45 Million in Series A Financing 11
Revolution Medicines Enters into Licensing Agreement with University of Illinois 12
Revolution Medicines Inc, Key Competitors 13
Revolution Medicines Inc, Key Employees 14

★海外企業調査レポート[Revolution Medicines Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Naftna industrija Srbije ad (NIIS):電力:M&Aディール及び事業提携情報
    Summary Naftna industrija Srbije ad (NIS), a subsidiary of Gazprom Neft, is an integrated energy company that conducts oil and gas exploration, production and refining, and sales and distribution of a broad range of petroleum products. Its refined products include motor fuel, diesel fuel, heating oi …
  • National Taiwan University Hospital-製薬・医療分野:企業M&A・提携分析
    Summary National Taiwan University Hospital (NTUH) is a healthcare service provider that offers biomedical, clinical research and patient care services. The hospital’s research activities include community-based intervention programs, multicenter controlled clinical trials, program projects, researc …
  • Dartmouth College-製薬・医療分野:企業M&A・提携分析
    Summary Dartmouth College (Dartmouth) is an academic and research institute that offers undergraduate and graduate educational programs. The institute offers programs in the fields of arts, sciences, business administration, medicine, and engineering. It operates through various faculties such as th …
  • Precision Drilling Corporation (PD):石油・ガス:M&Aディール及び事業提携情報
    Summary Precision Drilling Corp (Precision) is a provider of onshore drilling and production services to exploration and production companies in the oil and natural gas industry. It offers contract drilling, well servicing and other support services to oil and natural gas exploration and production …
  • Agile Therapeutics Inc (AGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Soitec SA (SOI):企業の財務・戦略的SWOT分析
    Soitec SA (SOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tokyo Electric Power Company Holdings Incorporated (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Incorporated (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • Polaris Industries Inc (PII):企業の財務・戦略的SWOT分析
    Polaris Industries Inc (PII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MagForce AG (MF6):医療機器:M&Aディール及び事業提携情報
    Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Fubon Bank (Hong Kong) Limited:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Minerals Technologies Inc (MTX):企業の財務・戦略的SWOT分析
    Minerals Technologies Inc (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Optum Inc-医療機器分野:企業M&A・提携分析
    Summary Optum Inc (Optum), a subsidiary of UnitedHealth Group Inc is a healthcare service provider that offers health IT, pharmacy care services, population health management, data and analytics, financial services, health care delivery, revenue cycle management, and health plan operations. The comp …
  • Hogan Lovells International LLP:企業の戦略的SWOT分析
    Hogan Lovells International LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Murphy Oil Corp (MUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company operates oil and gas fields in the US, Canada, Malaysia, Australia, Brunei, Vietnam and Mexico. M …
  • Murphy Oil Corporation:企業の戦略・SWOT・財務情報
    Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Arag Group:企業の戦略・SWOT・財務分析
    The Arag Group - Strategy, SWOT and Corporate Finance Report Summary The Arag Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆